💡 Key Learnings
Telehealth + Pharmacy = New Power Players
Old Model: Doctor → Prescription → Pharmacy. New Model: App → AI Consultation → Direct-to-Consumer. Traditional pharmacies are being disintermediated. The future is vertical integration (diagnosis...
Compounding Pharmacies = Major Disruption
Brand-name drugs are expensive. Compounding pharmacies make copies at fraction of cost in regulatory gray zone. Every blockbuster drug will have compounded alternatives. Pharma pricing power...
The Fast Follower Pharma Model
Wait for FDA approval → Launch copycat → No R&D costs. This means less incentive for original drug development. Big Pharma may shift to licensing vs direct sales. More M&A to buy innovators before...
Regulation Will Be the Battleground
Two scenarios: Lax regulation = telehealth boom, more compounding, innovation slows, patient safety risks. Strict enforcement = traditional pharma protected, compounding restricted, R&D incentives...
Consumer Behavior is Changing
Patients want: convenience (home delivery), cash-pay to skip insurance, trust influencers as much as doctors, demand pricing transparency. Future pharmacy = Amazon-like: subscriptions, same-day...
MENA Opportunity
Opportunity: Launch telehealth + pharmacy platforms. Challenge: Regulatory frameworks underdeveloped. Model to watch: Amazon Pharmacy, Hims, Ro. Key success factor: Trust + last-mile delivery. The...